Live Breaking News & Updates on Hans Kolam

Stay updated with breaking news from Hans kolam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Active Biotech Announcements | Active Biotech: Annual General Meeting of Active Biotech AB

Investegate announcements from Active Biotech, Annual General Meeting of Active Biotech AB ....

Hans Kolam , Uli Hacksell , Axel Glasmacher , Elaine Sullivan , Aleksandar Danilovski , Michael Shalmi , Peter Thelin , Election Committee , Annual General Meeting , Active Biotech , Investegate Announcements , Investegate Company Announcements , Active Biotech , Lobenewswire And Globenewswire ,

Annual General Meeting of Active Biotech AB

The Annual General Meeting of Active Biotech was held on May 19, 2022. Due to the situation resulting from the Corona virus, the Meeting was carried out through postal voting, without any physical attendance. ....

Hans Kolam , Uli Hacksell , Axel Glasmacher , Elaine Sullivan , Aleksandar Danilovski , Michael Shalmi , Peter Thelin , Election Committee , Annual General Meeting , Active Biotech ,

Active Biotech: FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis

Lund May 18, 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the U.S. Food and Drug Administration (FDA) has granted tasquinimod Orphan Drug Designation for the treatment of myelofibrosis. "The ....

Hans Kolam , Loncode Institute , Erasmus University Medical Center , Drug Administration , Lund May , Nasdaq Stockholm , Orphan Drug Designation , Drug Designation , Active Biotech ,

Annual Report 2021 Active Biotech AB (publ)

Active Biotech's Annual Report 2021 is now available for download at www.activebiotech.com. The Annual Report will only be digitally distributed. Download as PDF Lund, April 28, 2022 Active ....

Hans Kolam , Active Biotech , Annual Report , Securities Markets ,

Investegate |Active Biotech Announcements | Active Biotech: Active Biotech strengthens the patent protection for laquinimod in eye disorders

Investegate announcements from Active Biotech, Active Biotech strengthens the patent protection for laquinimod in eye disorders ....

Hans Kolam , Helen Tuvesson , European Patent Office , Us Patent Office , Active Biotech , Investegate Announcements , Investegate Company Announcements , Active Biotech , Lobenewswire And Globenewswire ,